Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BRKR | Common Stock | Options Exercise | $1.31M | +43.8K | +0.11% | $29.78 | 38.5M | Feb 17, 2022 | Direct | |
transaction | BRKR | Common Stock | Sale | -$1.78M | -26.2K | -0.07% | $68.12 | 38.5M | Feb 17, 2022 | Direct | F3, F5 |
transaction | BRKR | Common Stock | Options Exercise | $1.21M | +40.5K | +0.11% | $29.78 | 38.5M | Feb 18, 2022 | Direct | |
transaction | BRKR | Common Stock | Sale | -$1.84M | -26.8K | -0.07% | $68.51 | 38.5M | Feb 18, 2022 | Direct | F4, F6 |
holding | BRKR | Common Stock | 337K | Feb 17, 2022 | By Son | F1 | |||||
holding | BRKR | Common Stock | 337K | Feb 17, 2022 | By Daughter | F1 | |||||
holding | BRKR | Common Stock | 71.7K | Feb 17, 2022 | As UTMA custodian for son | ||||||
holding | BRKR | Common Stock | 202K | Feb 17, 2022 | As UTMA custodian for son | ||||||
holding | BRKR | Common Stock | 1.05M | Feb 17, 2022 | By Former Spouse | F1 | |||||
holding | BRKR | Common Stock | 492 | Feb 17, 2022 | By Former Spouse | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BRKR | Stock Option (Right to Buy) | Options Exercise | $0 | -43.8K | -100% | $0.00* | 0 | Feb 17, 2022 | Common Stock | 43.8K | $29.78 | Direct | F2 |
transaction | BRKR | Stock Option (Right to Buy) | Options Exercise | $0 | -40.5K | -100% | $0.00* | 0 | Feb 18, 2022 | Common Stock | 40.5K | $29.78 | Direct | F2 |
Id | Content |
---|---|
F1 | The reporting person disclaims beneficial ownership of 1,046,499 shares held by the reporting person's former spouse, 492 shares held by the reporting person's spouse, 337,087 shares held by the reporting person's adult son and 336,607 shares held by the reporting person's adult daughter, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. |
F2 | The stock option granted to the Reporting Person on August 10, 2017 (the "Original Grant Date") vested in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. |
F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.91 to $68.38, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.13 to $68.75, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
F5 | Reflects 26,200 shares sold by the Reporting Person at the market price of $68.12 per share less an exercise price of $29.777 per share to fund the cashless exercise of 43,847 options. |
F6 | Reflects 26,790 shares sold by the Reporting Person at the market price of $68.5068 per share less an exercise price of $29.777 per share to fund the cashless exercise of 40,490 options. |